“Burst” Exercise Leads to Greater Cardiometabolic Improvements in Patients with Type 2 Diabetes
Researchers studied 76 patients with type 2 diabetes randomly assigned to either 30 minutes of exercise 5 days per week at 65% of their target heart rate, or 10 minutes of exercise 3 times per day, 5 days per week at 85% of their target heart rate. The “burst” exercisers experienced a 2.3-fold greater improvement […]
New “Fingerprint” of Inflammation Identified in Obesity-Associated T2DM
Researchers at Boston University School of Medicine have identified a new “fingerprint” of inflammation that may be able to predict which patients with obesity may also develop type 2 diabetes. Specifically, inflammatory proteins known as Th17 cells, which are associated with autoimmune conditions, were identified as major contributors to inflammation and hyperglycemia. Although research has […]
Lixisenatide Proves Safety in ELIXA While Liraglutide Shows Greater HbA1c Reduction Compared with SGLT-2 Inhibitors
CV outcomes data from the ELIXA trial have been published in the New England Journal of Medicine for the as-yet FDA unapproved GLP-1 agonist lixisenatide, and have shown no increase or decrease in the rate of major cardiovascular events in patients with acute coronary syndrome. Read more here. Meanwhile, findings from a recent meta-analysis have […]
Are Newest Screening Recommendations for Type 2 Diabetes Falling Short?
In an update to their 2008 recommendations, the US Preventive Services Task Force (USPSTF) is calling for screening of overweight and obese adults between 40 and 70 years of age for abnormal blood glucose levels and type 2 diabetes. The recommendation applies to individuals being seen in primary care settings with no symptoms of type […]
Bariatric Surgery Appears to Cure Half of Patients with T2DM for at Least 5 Years
In a study of obese patients with type 2 diabetes, bariatric surgery was found to be more effective than medical treatment in the long-term control of the disease (for at least 5 years). The study consisted of 60 patients randomized to either medical treatment or surgery (Roux-en-Y gastric bypass or biliopancreatic diversion). The primary endpoint […]
Elevated Blood Pressure Increases Risk of Type 2 Diabetes
Results of a recent study published in the Journal of the American College of Cardiology are lending weight to the widely believed hypothesis that hypertension is an independent risk factor for type 2 diabetes. The study, an analysis of electronic health records and a meta-analysis, consisted of 4.1 million adults without diabetes and cardiovascular disease. […]
AHA/ADA Updates Scientific Statement on CVD Prevention for Patients with Type 2 Diabetes
In an update to their previous 2007 statement, the AHA and ADA recently presented a review of the current literature and key clinical trials regarding blood pressure and glucose control, cholesterol management, aspirin therapy, and lifestyle modification for primary prevention of CVD in patients with type 2 diabetes. Both the AHA and ADA believed an […]
Optimizing Insulin Regimens in Type 2 Diabetes
Dr. Robert Tanenberg provides a clinical snapshot of new options for optimizing insulin regimens for patients with type 2 diabetes.
